Bone disease in pediatric idiopathic hypercalciuria

Area of Science:

• Nephrology
• Endocrinology
• Metabolic Bone Disease

Background:

• Idiopathic hypercalciuria (IH) is a primary metabolic risk factor for urolithiasis.
• IH affects all age groups and is associated with reduced bone mineral density (BMD).
• The complex pathogenesis involves calcium homeostasis interplay between gut, bone, and kidney, influenced by hormones.

Purpose of the Study:

• To review the pathogenesis of idiopathic hypercalciuria.
• To explore the consequences of IH on bone mass accrual and maintenance.
• To elucidate the mechanisms underlying bone loss in IH patients.

Main Methods:

• Literature review of studies on idiopathic hypercalciuria and bone mineral density.
• Analysis of hormonal regulation of calcium homeostasis.
• Examination of cellular transport of calcium in intestines, kidneys, and bones.

Main Results:

• IH is a systemic abnormality affecting calcium homeostasis.
• Reduced BMD is observed in pediatric and adult IH patients.
• Mechanisms of bone loss or impaired bone mass gain in IH remain unclear.

Conclusions:

• IH impacts bone health, potentially leading to reduced peak bone mass and increased fracture risk.
• Further research is needed to understand the precise mechanisms of bone loss in IH.
• Addressing IH may be critical for optimizing bone health throughout the lifespan.